Share Price and Basic Stock Data
Last Updated: December 13, 2025, 9:23 am
| PEG Ratio | 2.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Zensar Technologies Ltd operates in the IT consulting and software sector, a space that has witnessed significant changes in recent years. As of its latest reporting period, the company recorded total sales of ₹5,378 Cr for the trailing twelve months (TTM), marking a notable increase from ₹4,848 Cr in the previous year. This upward trajectory in revenue is supported by consistent quarterly performance, with sales rising from ₹1,203 Cr in June 2022 to ₹1,385 Cr by June 2025. The growth reflects not just resilience but also Zensar’s ability to adapt to market demands and capitalize on emerging technologies, which is crucial in an industry characterized by rapid innovation.
Profitability and Efficiency Metrics
Profitability metrics for Zensar portray a generally strong performance, albeit with some fluctuations. The operating profit margin (OPM) stood at a respectable 15% for the TTM, although it peaked at 19% in June 2023 before settling back. Net profit for the same period was reported at ₹674 Cr, translating into an earnings per share (EPS) of ₹28.65, which reflects solid profitability compared to historical figures. Furthermore, Zensar’s return on equity (ROE) at 16.4% and return on capital employed (ROCE) at 21.3% indicate effective management of resources. However, the company must navigate challenges such as rising operational costs and competitive pressures that could impact these margins moving forward.
Balance Sheet Strength and Financial Ratios
Zensar’s balance sheet appears robust, with total borrowings reported at just ₹117 Cr, indicating a low debt profile that supports financial stability. The company boasts total reserves of ₹4,234 Cr, which provides a cushion against economic fluctuations and supports ongoing investments. The interest coverage ratio (ICR) is particularly noteworthy at 56.47x, suggesting that Zensar generates ample earnings to cover its interest expenses, a strong position in the context of rising interest rates. However, the price-to-book value (P/BV) ratio of 3.91x may indicate that the stock is trading at a premium, which could be a concern for value-focused investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Zensar Technologies reveals a healthy distribution of ownership, with promoters holding 49.03% of the stake. This significant ownership can instill confidence among retail investors as it indicates a vested interest in the company’s performance. Additionally, the presence of foreign institutional investors (FIIs) at 13.30% and domestic institutional investors (DIIs) at 22.24% reflects a positive sentiment towards Zensar. However, the public shareholding has gradually declined to 15.43%, which may raise questions about retail investor confidence. Continuous monitoring of these trends will be essential as they can influence market perceptions and stock performance.
Outlook, Risks, and Final Insight
Looking ahead, Zensar Technologies faces both opportunities and challenges. The company’s strong revenue growth and profitability metrics suggest a positive outlook, particularly as digital transformation continues to gain momentum across industries. However, risks such as global economic uncertainties and increasing competition in the IT sector could pose hurdles. Investors should remain cautious about market dynamics and potential impacts on margins. Overall, Zensar appears to be well-positioned with a solid balance sheet and effective management practices. Yet, as with any investment, it is crucial to weigh these strengths against the inherent risks before making decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 12.5 Cr. | 21.2 | 21.2/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 112 Cr. | 69.2 | 101/17.6 | 55.1 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 11.8 Cr. | 40.8 | 64.9/33.1 | 8.00 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 25.8 Cr. | 75.0 | 200/67.0 | 17.5 | 15.0 | 1.33 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 123,249.19 Cr | 819.85 | 46.93 | 158.22 | 0.77% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,203 | 1,235 | 1,198 | 1,213 | 1,227 | 1,241 | 1,204 | 1,230 | 1,288 | 1,308 | 1,326 | 1,359 | 1,385 |
| Expenses | 1,067 | 1,129 | 1,063 | 1,037 | 997 | 1,010 | 996 | 1,027 | 1,092 | 1,107 | 1,119 | 1,146 | 1,174 |
| Operating Profit | 136 | 105 | 135 | 176 | 230 | 231 | 208 | 203 | 196 | 201 | 207 | 212 | 211 |
| OPM % | 11% | 9% | 11% | 14% | 19% | 19% | 17% | 17% | 15% | 15% | 16% | 16% | 15% |
| Other Income | 21 | 28 | 26 | 27 | 28 | 36 | 42 | 52 | 42 | 41 | 31 | 46 | 57 |
| Interest | 6 | 8 | 8 | 6 | 6 | 6 | 6 | 3 | 4 | 4 | 4 | 5 | 4 |
| Depreciation | 49 | 49 | 50 | 35 | 42 | 37 | 31 | 24 | 25 | 30 | 24 | 24 | 23 |
| Profit before tax | 102 | 77 | 104 | 162 | 210 | 225 | 212 | 229 | 210 | 208 | 210 | 230 | 241 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 23% | 24% | 24% | 25% | 25% | 24% | 23% | 24% |
| Net Profit | 75 | 57 | 76 | 119 | 156 | 174 | 162 | 173 | 158 | 156 | 160 | 176 | 182 |
| EPS in Rs | 3.32 | 2.51 | 3.38 | 5.27 | 6.90 | 7.68 | 7.14 | 7.65 | 6.97 | 6.86 | 7.04 | 7.77 | 8.01 |
Last Updated: August 1, 2025, 9:00 am
Below is a detailed analysis of the quarterly data for Zensar Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,385.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,359.00 Cr. (Mar 2025) to 1,385.00 Cr., marking an increase of 26.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,174.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,146.00 Cr. (Mar 2025) to 1,174.00 Cr., marking an increase of 28.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 211.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Mar 2025) to 211.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 15.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 57.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Jun 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 24.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 241.00 Cr.. The value appears strong and on an upward trend. It has increased from 230.00 Cr. (Mar 2025) to 241.00 Cr., marking an increase of 11.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 176.00 Cr. (Mar 2025) to 182.00 Cr., marking an increase of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.01. The value appears strong and on an upward trend. It has increased from 7.77 (Mar 2025) to 8.01, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:07 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,335 | 2,656 | 2,952 | 3,056 | 3,108 | 3,966 | 4,182 | 3,781 | 4,244 | 4,848 | 4,902 | 5,281 | 5,378 |
| Expenses | 1,977 | 2,264 | 2,513 | 2,674 | 2,743 | 3,487 | 3,689 | 3,097 | 3,587 | 4,296 | 4,030 | 4,464 | 4,546 |
| Operating Profit | 358 | 392 | 439 | 382 | 365 | 479 | 493 | 685 | 656 | 552 | 872 | 817 | 831 |
| OPM % | 15% | 15% | 15% | 12% | 12% | 12% | 12% | 18% | 15% | 11% | 18% | 15% | 15% |
| Other Income | 30 | 27 | 54 | 24 | 74 | 93 | 88 | -24 | 138 | 103 | 159 | 160 | 174 |
| Interest | 10 | 11 | 11 | 9 | 23 | 37 | 61 | 54 | 35 | 28 | 21 | 17 | 17 |
| Depreciation | 38 | 42 | 65 | 49 | 65 | 89 | 159 | 175 | 185 | 183 | 134 | 102 | 100 |
| Profit before tax | 340 | 366 | 417 | 349 | 352 | 445 | 362 | 433 | 574 | 444 | 876 | 858 | 889 |
| Tax % | 30% | 28% | 30% | 32% | 30% | 28% | 25% | 29% | 27% | 26% | 24% | 24% | |
| Net Profit | 238 | 265 | 292 | 238 | 246 | 319 | 272 | 307 | 422 | 328 | 665 | 650 | 674 |
| EPS in Rs | 10.86 | 11.94 | 12.97 | 10.47 | 10.74 | 13.93 | 11.69 | 13.30 | 18.40 | 14.47 | 29.34 | 28.61 | 29.68 |
| Dividend Payout % | 18% | 18% | 18% | 23% | 22% | 20% | 24% | 27% | 27% | 35% | 31% | 45% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 11.34% | 10.19% | -18.49% | 3.36% | 29.67% | -14.73% | 12.87% | 37.46% | -22.27% | 102.74% | -2.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.16% | -28.68% | 21.85% | 26.31% | -44.41% | 27.60% | 24.59% | -59.73% | 125.02% | -105.00% |
Zensar Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 8% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 20% |
| 3 Years: | 15% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 35% |
| 3 Years: | 50% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: December 10, 2025, 3:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 44 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 46 |
| Reserves | 902 | 1,113 | 1,220 | 1,427 | 1,624 | 1,897 | 2,045 | 2,297 | 2,642 | 2,931 | 3,517 | 4,024 | 4,234 |
| Borrowings | 170 | 176 | 149 | 134 | 9 | 300 | 332 | 350 | 335 | 273 | 186 | 125 | 117 |
| Other Liabilities | 370 | 402 | 455 | 500 | 618 | 847 | 1,174 | 742 | 817 | 872 | 899 | 978 | 1,016 |
| Total Liabilities | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 5,412 |
| Fixed Assets | 422 | 547 | 386 | 447 | 592 | 950 | 1,323 | 1,133 | 1,254 | 1,174 | 1,034 | 1,170 | 1,184 |
| CWIP | 2 | 1 | 2 | 3 | 6 | 12 | 11 | 0 | 1 | 0 | 5 | 1 | 6 |
| Investments | 149 | 94 | 134 | 243 | 275 | 115 | 278 | 517 | 324 | 899 | 1,408 | 1,714 | 1,594 |
| Other Assets | 914 | 1,092 | 1,347 | 1,413 | 1,424 | 2,013 | 1,983 | 1,783 | 2,260 | 2,049 | 2,200 | 2,288 | 2,628 |
| Total Assets | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 5,412 |
Below is a detailed analysis of the balance sheet data for Zensar Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,234.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,024.00 Cr. (Mar 2025) to 4,234.00 Cr., marking an increase of 210.00 Cr..
- For Borrowings, as of Sep 2025, the value is 117.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 125.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,016.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 978.00 Cr. (Mar 2025) to 1,016.00 Cr., marking an increase of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,184.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,170.00 Cr. (Mar 2025) to 1,184.00 Cr., marking an increase of 14.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 5.00 Cr..
- For Investments, as of Sep 2025, the value is 1,594.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,714.00 Cr. (Mar 2025) to 1,594.00 Cr., marking a decrease of 120.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,628.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,288.00 Cr. (Mar 2025) to 2,628.00 Cr., marking an increase of 340.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,412.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..
Notably, the Reserves (4,234.00 Cr.) exceed the Borrowings (117.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 188.00 | 216.00 | 290.00 | 248.00 | 356.00 | 179.00 | 161.00 | 335.00 | 321.00 | 279.00 | 686.00 | 692.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 62 | 67 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 |
| Inventory Days | 272 | 266 | 304 | |||||||||
| Days Payable | 300 | 283 | 400 | |||||||||
| Cash Conversion Cycle | 28 | 45 | -29 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 |
| Working Capital Days | 44 | 41 | 56 | 49 | 70 | 57 | 20 | 19 | 36 | 21 | 27 | 30 |
| ROCE % | 34% | 30% | 31% | 24% | 23% | 23% | 17% | 21% | 21% | 15% | 25% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Hybrid Equity Fund | 5,578,744 | 1.8 | 444.93 | N/A | N/A | N/A |
| HDFC Small Cap Fund | 5,244,616 | 1.09 | 418.28 | N/A | N/A | N/A |
| Franklin India Small Cap Fund | 3,220,340 | 1.86 | 256.84 | N/A | N/A | N/A |
| HSBC Value Fund | 2,508,911 | 1.4 | 200.1 | 2,546,500 | 2025-11-03 17:59:58 | -1.48% |
| Nippon India Small Cap Fund | 2,496,604 | 0.29 | 199.12 | 4,039,176 | 2025-05-25 10:25:42 | -38.19% |
| Invesco India Smallcap Fund | 1,672,012 | 1.53 | 133.35 | N/A | N/A | N/A |
| Tata Digital India Fund | 1,601,303 | 1.08 | 127.71 | 1,965,123 | 2025-05-25 10:25:42 | -18.51% |
| HDFC Childrens Fund | 1,521,492 | 1.15 | 121.35 | N/A | N/A | N/A |
| ICICI Prudential Technology Fund | 1,451,910 | 0.76 | 115.8 | 1,570,526 | 2025-11-03 17:59:58 | -7.55% |
| HDFC Multi Cap Fund | 1,070,174 | 0.43 | 85.35 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 28.65 | 29.36 | 14.47 | 18.43 | 13.31 |
| Diluted EPS (Rs.) | 28.43 | 29.13 | 14.40 | 18.27 | 13.18 |
| Cash EPS (Rs.) | 33.11 | 35.27 | 22.54 | 26.84 | 21.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 179.28 | 157.26 | 131.40 | 118.89 | 105.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 179.28 | 157.26 | 131.40 | 118.89 | 105.10 |
| Revenue From Operations / Share (Rs.) | 232.63 | 216.42 | 214.05 | 187.78 | 167.61 |
| PBDIT / Share (Rs.) | 43.04 | 45.50 | 28.92 | 35.14 | 31.48 |
| PBIT / Share (Rs.) | 38.55 | 39.59 | 20.84 | 26.96 | 23.74 |
| PBT / Share (Rs.) | 37.78 | 38.67 | 19.61 | 25.40 | 19.19 |
| Net Profit / Share (Rs.) | 28.63 | 29.36 | 14.46 | 18.66 | 13.61 |
| NP After MI And SOA / Share (Rs.) | 28.63 | 29.36 | 14.46 | 18.42 | 13.30 |
| PBDIT Margin (%) | 18.49 | 21.02 | 13.51 | 18.71 | 18.78 |
| PBIT Margin (%) | 16.57 | 18.29 | 9.73 | 14.35 | 14.16 |
| PBT Margin (%) | 16.24 | 17.86 | 9.16 | 13.52 | 11.44 |
| Net Profit Margin (%) | 12.30 | 13.56 | 6.75 | 9.93 | 8.11 |
| NP After MI And SOA Margin (%) | 12.30 | 13.56 | 6.75 | 9.80 | 7.93 |
| Return on Networth / Equity (%) | 15.96 | 18.66 | 11.00 | 15.49 | 12.80 |
| Return on Capital Employeed (%) | 20.39 | 23.63 | 14.46 | 20.03 | 19.87 |
| Return On Assets (%) | 12.56 | 14.30 | 7.94 | 10.75 | 8.73 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Asset Turnover Ratio (%) | 1.08 | 1.12 | 1.21 | 0.54 | 0.46 |
| Current Ratio (X) | 3.76 | 3.04 | 2.70 | 2.73 | 2.70 |
| Quick Ratio (X) | 3.76 | 3.04 | 2.70 | 2.73 | 2.70 |
| Dividend Payout Ratio (NP) (%) | 31.40 | 18.73 | 34.55 | 21.16 | 9.01 |
| Dividend Payout Ratio (CP) (%) | 27.15 | 15.59 | 22.16 | 14.65 | 5.69 |
| Earning Retention Ratio (%) | 68.60 | 81.27 | 65.45 | 78.84 | 90.99 |
| Cash Earning Retention Ratio (%) | 72.85 | 84.41 | 77.84 | 85.35 | 94.31 |
| Interest Coverage Ratio (X) | 56.47 | 49.31 | 23.48 | 22.50 | 13.27 |
| Interest Coverage Ratio (Post Tax) (X) | 38.56 | 32.82 | 12.74 | 12.95 | 7.65 |
| Enterprise Value (Cr.) | 15171.37 | 12988.21 | 5476.97 | 7684.40 | 5517.20 |
| EV / Net Operating Revenue (X) | 2.87 | 2.65 | 1.13 | 1.81 | 1.46 |
| EV / EBITDA (X) | 15.53 | 12.60 | 8.36 | 9.68 | 7.77 |
| MarketCap / Net Operating Revenue (X) | 3.01 | 2.80 | 1.28 | 1.96 | 1.64 |
| Retention Ratios (%) | 68.59 | 81.26 | 65.44 | 78.83 | 90.98 |
| Price / BV (X) | 3.91 | 3.85 | 2.08 | 3.09 | 2.64 |
| Price / Net Operating Revenue (X) | 3.01 | 2.80 | 1.28 | 1.96 | 1.64 |
| EarningsYield | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 |
After reviewing the key financial ratios for Zensar Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 28.65. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.65, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is 28.43. This value is within the healthy range. It has decreased from 29.13 (Mar 24) to 28.43, marking a decrease of 0.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 33.11. This value is within the healthy range. It has decreased from 35.27 (Mar 24) to 33.11, marking a decrease of 2.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.63. It has increased from 216.42 (Mar 24) to 232.63, marking an increase of 16.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.04. This value is within the healthy range. It has decreased from 45.50 (Mar 24) to 43.04, marking a decrease of 2.46.
- For PBIT / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has decreased from 39.59 (Mar 24) to 38.55, marking a decrease of 1.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 37.78. This value is within the healthy range. It has decreased from 38.67 (Mar 24) to 37.78, marking a decrease of 0.89.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
- For PBDIT Margin (%), as of Mar 25, the value is 18.49. This value is within the healthy range. It has decreased from 21.02 (Mar 24) to 18.49, marking a decrease of 2.53.
- For PBIT Margin (%), as of Mar 25, the value is 16.57. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 16.57, marking a decrease of 1.72.
- For PBT Margin (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 16.24, marking a decrease of 1.62.
- For Net Profit Margin (%), as of Mar 25, the value is 12.30. This value exceeds the healthy maximum of 10. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.96. This value is within the healthy range. It has decreased from 18.66 (Mar 24) to 15.96, marking a decrease of 2.70.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has decreased from 23.63 (Mar 24) to 20.39, marking a decrease of 3.24.
- For Return On Assets (%), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 12.56, marking a decrease of 1.74.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has decreased from 1.12 (Mar 24) to 1.08, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
- For Quick Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 2. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 31.40, marking an increase of 12.67.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.15. This value is within the healthy range. It has increased from 15.59 (Mar 24) to 27.15, marking an increase of 11.56.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.60. This value is within the healthy range. It has decreased from 81.27 (Mar 24) to 68.60, marking a decrease of 12.67.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.85. This value exceeds the healthy maximum of 70. It has decreased from 84.41 (Mar 24) to 72.85, marking a decrease of 11.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 56.47. This value is within the healthy range. It has increased from 49.31 (Mar 24) to 56.47, marking an increase of 7.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 38.56. This value is within the healthy range. It has increased from 32.82 (Mar 24) to 38.56, marking an increase of 5.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,171.37. It has increased from 12,988.21 (Mar 24) to 15,171.37, marking an increase of 2,183.16.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 2.87, marking an increase of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has increased from 12.60 (Mar 24) to 15.53, marking an increase of 2.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
- For Retention Ratios (%), as of Mar 25, the value is 68.59. This value is within the healthy range. It has decreased from 81.26 (Mar 24) to 68.59, marking a decrease of 12.67.
- For Price / BV (X), as of Mar 25, the value is 3.91. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 3.91, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zensar Technologies Ltd:
- Net Profit Margin: 12.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.39% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.96% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 38.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.9 (Industry average Stock P/E: 46.93)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Zensar Knowledge Park, Plot # 4, MIDC Kharadi, Pune Maharashtra 411014 | investor@zensar.com http://www.zensar.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. H V Goenka | Chairman & Non-Exe.Director |
| Mr. Anant Vardhan Goenka | Vice Chairman & Non Exe.Dire |
| Mr. Manish Tandon | Managing Director & CEO |
| Mr. Ketan Dalal | Ind. Non-Executive Director |
| Mr. Ben Druskin | Ind. Non-Executive Director |
| Ms. Radha Rajappa | Ind. Non-Executive Director |
| Mr. U B Pravin Rao | Ind. Non-Executive Director |
| Mr. Harsh Mariwala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Zensar Technologies Ltd?
Zensar Technologies Ltd's intrinsic value (as of 13 December 2025) is 599.94 which is 18.49% lower the current market price of 736.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 16,737 Cr. market cap, FY2025-2026 high/low of 985/536, reserves of ₹4,234 Cr, and liabilities of 5,412 Cr.
What is the Market Cap of Zensar Technologies Ltd?
The Market Cap of Zensar Technologies Ltd is 16,737 Cr..
What is the current Stock Price of Zensar Technologies Ltd as on 13 December 2025?
The current stock price of Zensar Technologies Ltd as on 13 December 2025 is 736.
What is the High / Low of Zensar Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Zensar Technologies Ltd stocks is 985/536.
What is the Stock P/E of Zensar Technologies Ltd?
The Stock P/E of Zensar Technologies Ltd is 23.9.
What is the Book Value of Zensar Technologies Ltd?
The Book Value of Zensar Technologies Ltd is 188.
What is the Dividend Yield of Zensar Technologies Ltd?
The Dividend Yield of Zensar Technologies Ltd is 1.77 %.
What is the ROCE of Zensar Technologies Ltd?
The ROCE of Zensar Technologies Ltd is 21.3 %.
What is the ROE of Zensar Technologies Ltd?
The ROE of Zensar Technologies Ltd is 16.4 %.
What is the Face Value of Zensar Technologies Ltd?
The Face Value of Zensar Technologies Ltd is 2.00.